Replication of the Wellcome Trust genome-wide association study of essential hypertension: The Family Blood Pressure Program

Georg B. Ehret, Alanna C. Morrison, Ashley A. O'Connor, Megan L. Grove, Lisa Baird, Karen Schwander, Alan Weder, Richard S. Cooper, D. C. Rao, Steven Hunt, Eric Boerwinkle, Aravinda Chakravarti

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Essential hypertension is a principal cardiovascular risk factor whose origin remains unknown. Classical genetic studies have shown that blood pressure is at least partially heritable, opening a window to understanding the pathophysiology of essential hypertension in the human using modern genetic tools. The Wellcome Trust Case Control Consortium has recently published the results of screening the genomes of 2000 essential hypertension cases and 3000 controls using 500000 genome-wide single nucleotide polymorphisms (SNPs). None of the variants proved to be genome-wide significant after correction for multiple tests but the most significantly associated SNPs (P<10-5) constitute a priority list that warrant follow-up in other studies. We describe here replication studies of the top six SNPs in subjects from the US National Heart, Lung, and Blood Institute funded Family Blood Pressure Program comprising 11433 individuals recruited by hypertensive families. The results suggest that only one of the six SNPs might be associated with essential hypertension in Americans of European origin. This SNP shows a significant but opposite effect in Americans of Hispanic origin and no association in African Americans. The significance of the opposing effect estimates is unclear. No replication could be shown for hypertension status, but there are differences in study design. This attempted replication highlights that essential hypertension studies will require more comprehensive and larger genetic screens.

Original languageEnglish
Pages (from-to)1507-1511
Number of pages5
JournalEuropean Journal of Human Genetics
Volume16
Issue number12
DOIs
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Genome-Wide Association Study
Single Nucleotide Polymorphism
Blood Pressure
Genome
National Heart, Lung, and Blood Institute (U.S.)
Hispanic Americans
African Americans
Essential Hypertension
Hypertension

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Ehret, G. B., Morrison, A. C., O'Connor, A. A., Grove, M. L., Baird, L., Schwander, K., ... Chakravarti, A. (2008). Replication of the Wellcome Trust genome-wide association study of essential hypertension: The Family Blood Pressure Program. European Journal of Human Genetics, 16(12), 1507-1511. https://doi.org/10.1038/ejhg.2008.102

Replication of the Wellcome Trust genome-wide association study of essential hypertension : The Family Blood Pressure Program. / Ehret, Georg B.; Morrison, Alanna C.; O'Connor, Ashley A.; Grove, Megan L.; Baird, Lisa; Schwander, Karen; Weder, Alan; Cooper, Richard S.; Rao, D. C.; Hunt, Steven; Boerwinkle, Eric; Chakravarti, Aravinda.

In: European Journal of Human Genetics, Vol. 16, No. 12, 2008, p. 1507-1511.

Research output: Contribution to journalArticle

Ehret, GB, Morrison, AC, O'Connor, AA, Grove, ML, Baird, L, Schwander, K, Weder, A, Cooper, RS, Rao, DC, Hunt, S, Boerwinkle, E & Chakravarti, A 2008, 'Replication of the Wellcome Trust genome-wide association study of essential hypertension: The Family Blood Pressure Program', European Journal of Human Genetics, vol. 16, no. 12, pp. 1507-1511. https://doi.org/10.1038/ejhg.2008.102
Ehret, Georg B. ; Morrison, Alanna C. ; O'Connor, Ashley A. ; Grove, Megan L. ; Baird, Lisa ; Schwander, Karen ; Weder, Alan ; Cooper, Richard S. ; Rao, D. C. ; Hunt, Steven ; Boerwinkle, Eric ; Chakravarti, Aravinda. / Replication of the Wellcome Trust genome-wide association study of essential hypertension : The Family Blood Pressure Program. In: European Journal of Human Genetics. 2008 ; Vol. 16, No. 12. pp. 1507-1511.
@article{bcc1b1ba3cca4a37be5ca09b3c728f4a,
title = "Replication of the Wellcome Trust genome-wide association study of essential hypertension: The Family Blood Pressure Program",
abstract = "Essential hypertension is a principal cardiovascular risk factor whose origin remains unknown. Classical genetic studies have shown that blood pressure is at least partially heritable, opening a window to understanding the pathophysiology of essential hypertension in the human using modern genetic tools. The Wellcome Trust Case Control Consortium has recently published the results of screening the genomes of 2000 essential hypertension cases and 3000 controls using 500000 genome-wide single nucleotide polymorphisms (SNPs). None of the variants proved to be genome-wide significant after correction for multiple tests but the most significantly associated SNPs (P<10-5) constitute a priority list that warrant follow-up in other studies. We describe here replication studies of the top six SNPs in subjects from the US National Heart, Lung, and Blood Institute funded Family Blood Pressure Program comprising 11433 individuals recruited by hypertensive families. The results suggest that only one of the six SNPs might be associated with essential hypertension in Americans of European origin. This SNP shows a significant but opposite effect in Americans of Hispanic origin and no association in African Americans. The significance of the opposing effect estimates is unclear. No replication could be shown for hypertension status, but there are differences in study design. This attempted replication highlights that essential hypertension studies will require more comprehensive and larger genetic screens.",
author = "Ehret, {Georg B.} and Morrison, {Alanna C.} and O'Connor, {Ashley A.} and Grove, {Megan L.} and Lisa Baird and Karen Schwander and Alan Weder and Cooper, {Richard S.} and Rao, {D. C.} and Steven Hunt and Eric Boerwinkle and Aravinda Chakravarti",
year = "2008",
doi = "10.1038/ejhg.2008.102",
language = "English",
volume = "16",
pages = "1507--1511",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Replication of the Wellcome Trust genome-wide association study of essential hypertension

T2 - The Family Blood Pressure Program

AU - Ehret, Georg B.

AU - Morrison, Alanna C.

AU - O'Connor, Ashley A.

AU - Grove, Megan L.

AU - Baird, Lisa

AU - Schwander, Karen

AU - Weder, Alan

AU - Cooper, Richard S.

AU - Rao, D. C.

AU - Hunt, Steven

AU - Boerwinkle, Eric

AU - Chakravarti, Aravinda

PY - 2008

Y1 - 2008

N2 - Essential hypertension is a principal cardiovascular risk factor whose origin remains unknown. Classical genetic studies have shown that blood pressure is at least partially heritable, opening a window to understanding the pathophysiology of essential hypertension in the human using modern genetic tools. The Wellcome Trust Case Control Consortium has recently published the results of screening the genomes of 2000 essential hypertension cases and 3000 controls using 500000 genome-wide single nucleotide polymorphisms (SNPs). None of the variants proved to be genome-wide significant after correction for multiple tests but the most significantly associated SNPs (P<10-5) constitute a priority list that warrant follow-up in other studies. We describe here replication studies of the top six SNPs in subjects from the US National Heart, Lung, and Blood Institute funded Family Blood Pressure Program comprising 11433 individuals recruited by hypertensive families. The results suggest that only one of the six SNPs might be associated with essential hypertension in Americans of European origin. This SNP shows a significant but opposite effect in Americans of Hispanic origin and no association in African Americans. The significance of the opposing effect estimates is unclear. No replication could be shown for hypertension status, but there are differences in study design. This attempted replication highlights that essential hypertension studies will require more comprehensive and larger genetic screens.

AB - Essential hypertension is a principal cardiovascular risk factor whose origin remains unknown. Classical genetic studies have shown that blood pressure is at least partially heritable, opening a window to understanding the pathophysiology of essential hypertension in the human using modern genetic tools. The Wellcome Trust Case Control Consortium has recently published the results of screening the genomes of 2000 essential hypertension cases and 3000 controls using 500000 genome-wide single nucleotide polymorphisms (SNPs). None of the variants proved to be genome-wide significant after correction for multiple tests but the most significantly associated SNPs (P<10-5) constitute a priority list that warrant follow-up in other studies. We describe here replication studies of the top six SNPs in subjects from the US National Heart, Lung, and Blood Institute funded Family Blood Pressure Program comprising 11433 individuals recruited by hypertensive families. The results suggest that only one of the six SNPs might be associated with essential hypertension in Americans of European origin. This SNP shows a significant but opposite effect in Americans of Hispanic origin and no association in African Americans. The significance of the opposing effect estimates is unclear. No replication could be shown for hypertension status, but there are differences in study design. This attempted replication highlights that essential hypertension studies will require more comprehensive and larger genetic screens.

UR - http://www.scopus.com/inward/record.url?scp=56749149825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749149825&partnerID=8YFLogxK

U2 - 10.1038/ejhg.2008.102

DO - 10.1038/ejhg.2008.102

M3 - Article

C2 - 18523456

AN - SCOPUS:56749149825

VL - 16

SP - 1507

EP - 1511

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 12

ER -